![Seqens](https://www.pharmacompass.com/image/flap/seqens-corp-ad-w16-desktop-header-newgif-91648.gif)
![Seqens](https://www.pharmacompass.com/image/flap/seqens-corp-ad-w16-header-mobile-newgif-14167.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2020/09/02/2087762/0/en/Sorrento-Announces-the-Closing-of-Its-Acquisition-of-SmartPharm-to-Build-Next-Generation-G-MAB-Encoded-Plasmid-DNA-For-Cost-Efficient-and-In-Vivo-Production-of-Antibody-Therapeutic.html
http://www.globenewswire.com/news-release/2020/08/20/2081668/0/en/Sorrento-Enters-Into-Merger-Agreement-to-Acquire-SmartPharm-and-Develop-Pipeline-of-Gene-Encoded-Therapeutic-Antibodies-Starting-With-Neutralizing-Antibodies-to-Treat-COVID-19-and-.html
https://www.prnewswire.com/news-releases/sorrento-enters-into-letter-of-intent-to-acquire-smartpharm-and-develop-pipeline-of-gene-encoded-therapeutic-antibodies-starting-with-neutralizing-antibodies-to-treat-covid-19-and-cancer-therapeutics-301099317.html
https://pipelinereview.com/index.php/2020032374082/DNA-RNA-and-Cells/Sorrento-and-Smartpharm-to-collaborate-to-develop-novel-gene-encoded-antibody-vaccine-intended-to-protect-against-COVID-19.html